# Post-transplant Cyclophosphamide in Wiskott-Aldrich Syndrome

> **NCT03198195** · — · UNKNOWN · sponsor: **Capital Research Institute of Pediatrics** · enrollment: 5 (actual)

## Conditions studied

- Wiskott-Aldrich Syndrome

## Interventions

- **PROCEDURE:** cyclophosphamide

## Key facts

- **NCT ID:** NCT03198195
- **Lead sponsor:** Capital Research Institute of Pediatrics
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-03-10
- **Primary completion:** 2017-03-10
- **Final completion:** 2020-07-10
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2017-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03198195

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03198195, "Post-transplant Cyclophosphamide in Wiskott-Aldrich Syndrome". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03198195. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*